Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc. (DWTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DWTX · as of Jun 8, 2026
Key Statistics
Explore Dogwood Therapeutics, Inc. Data
dwtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
dwtx competitorsDWTX
BOLT
BRTX
CLRB
COCP
EDSAStock Performance
Full HistoryAbout Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions …
what is dogwood therapeutics, inc. · dwtx stock overview · dogwood therapeutics, inc. company profile · who is dogwood therapeutics, inc. ceo · dwtx NASDAQ · dogwood therapeutics, inc. headquarters · dogwood therapeutics, inc. business segments
About Stock Overview & Key Data
Dogwood Therapeutics, Inc. (DWTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 17, 2020. As of the latest trading session, DWTX stock price is $1.46, with a market capitalization of $2.8M. The stock has returned -69.88% over the past 12 months and -64.30% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Dogwood Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Dogwood Therapeutics, Inc. reported revenue of — and net income of -$34.3M. For detailed data — including Dogwood Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Dogwood Therapeutics, Inc. (DWTX) stock price is $1.46. The stock is traded on NASDAQ under the ticker symbol DWTX. The 52-week range is $1.28 – $9.50.